Hepatic Steatosis: Prevalence and Host/Viral Risk Factors in Iranian Patients with Chronic Hepatitis B Infection |
Poortahmasebi, Vahdat
(Hepatitis B Molecular Laboratory, Department of Virology, School of Public Health, Tehran University of Medical Sciences)
Alavian, Seyed Moayed (Middle East Liver Diseases Center (MELD Centers)) Keyvani, Hossein (Department of Virology, School of Medicine, Tehran University of Medical Sciences) Norouzi, Mehdi (Hepatitis B Molecular Laboratory, Department of Virology, School of Public Health, Tehran University of Medical Sciences) Mahmoodi, Mahmood (Department of epidemiology, School of Public Health, Tehran University of Medical Sciences) Jazayeri, Seyed Mohammad (Hepatitis B Molecular Laboratory, Department of Virology, School of Public Health, Tehran University of Medical Sciences) |
1 | Zheng RD, Xu CR, Jiang L, et al (2010). Predictors of hepatic steatosis in HBeAg-negative chronic hepatitis B patients and their diagnostic values in hepatic fibrosis. Int J Med Sci, 7, 272-7. |
2 | Lesmana LA, Lesmana CR, Pakasi LS, Krisnuhoni E (2012). Prevalence of hepatic steatosis in chronic hepatitis B patients and its association with disease severity. Acta Med Indones, 44, 35-9. |
3 | Kim KH, Shin HJ, Kim K, et al (2007). Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma. Gastroenterology, 132, 1955-67. DOI ScienceOn |
4 | Kim YC, Song KS, Yoon G, Nam MJ, Ryu WS (2001). Activated ras oncogene collaborates with HBx gene of hepatitis B virus to transform cells by suppressing HBx-mediated apoptosis. Oncogene, 20, 16-23. DOI ScienceOn |
5 | Lagging LM, Garcia CE, Westin J, et al (2002). Comparison of serum hepatitis C virus RNA and core antigen concentrations and determination of whether levels are associated with liver histology or affected by specimen storage time. J Clin Microbiol, 40, 4224-9. DOI |
6 | Lonardo A, Adinolfi LE, Loria P, et al (2004). Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease. Gastroenterology, 126, 586-97. DOI ScienceOn |
7 | Lonardo A, Loria P, Adinolfi LE, Carulli N, Ruggiero G (2006). Hepatitis C and steatosis: a reappraisal. J Viral Hepat, 13, 73-80. DOI |
8 | Malhotra V, Sakhuja P, Gondal R, et al (2000). Histological comparison of chronic hepatitis B and C in an Indian population. Trop Gastroenterol, 21, 20-1. |
9 | Altlparmak E, Koklu S, Yalinkilic M, et al (2005). Viral and host causes of fatty liver in chronic hepatitis B. World J Gastroenterol, 11, 3056-9. DOI |
10 | Cindoruk M, Karakan T, Unal S (2007). Hepatic steatosis has no impact on the outcome of treatment in patients with chronic hepatitis B infection. J Clin Gastroenterol, 41, 513-7. DOI ScienceOn |
11 | Tsochatzis E, Papatheodoridis GV, Manesis EK, et al (2007). Hepatic steatosis in chronic hepatitis B develops due to host metabolic factors: a comparative approach with genotype 1 chronic hepatitis C. Dig Liver Dis, 39, 936-42. DOI |
12 | Bondini S, Kallman J, Wheeler A, et al (2007). Impact of non-alcoholic fatty liver disease on chronic hepatitis B. Liver Int, 27, 607-11. DOI |
13 | Bugianesi E (2007). Non-alcoholic steatohepatitis and cancer. Clin Liver Dis, 11, 191-207. DOI |
14 | Fujie H, Yotsuyanagi H, Moriya K, et al (1999). Steatosis and intrahepatic hepatitis C virus in chronic hepatitis. J Med Virol, 59, 141-5. DOI |
15 | Harrison SA, Brunt EM, Qazi RA, et al (2005). Effect of significant histologic steatosis or steatohepatitis on response to antiviral therapy in patients with chronic hepatitis C. Clin Gastroenterol Hepatol, 3, 604-9. DOI ScienceOn |
16 | Jiang J, Nilsson-Ehle P, Xu N (2006). Influence of liver cancer on lipid and lipoprotein metabolism. Lipids Health Dis, 5, 4. DOI ScienceOn |
17 | Jin X, Chen YP, Yang YD, et al (2012). Association between hepatic steatosis and entecavir treatment failure in Chinese patients with chronic hepatitis B. PLoS One, 7, 34198. DOI |
18 | Powell EE, Jonsson JR,Clouston AD (2005). Steatosis: co-factor in other liver diseases. Hepatology, 42, 5-13. |
19 | Kim JY, Song EH, Lee HJ, et al (2010). HBx-induced hepatic steatosis and apoptosis are regulated by TNFR1- and NF-kappaB-dependent pathways. J Mol Biol, 397, 917-31. DOI ScienceOn |
20 | Roberts JM, Searle JW, Cooksley WG (1993). Histological patterns of prolonged hepatitis C infection. Gastroenterol Jpn, 28, 37-41. DOI ScienceOn |
21 | Rastogi A, Sakhuja P, Kumar A, et al (2011). Steatosis in chronic hepatitis B: prevalence and association with biochemical, histologic, viral, and metabolic parameters. Indian J Pathol Microbiol, 54, 454-9. DOI |
22 | Ratziu V, Trabut JB, Poynard T (2004). Fat, diabetes, and liver injury in chronic hepatitis C. Curr Gastroenterol Rep, 6, 22-9. DOI |
23 | Sass DA, Chang P, Chopra KB (2005). Nonalcoholic fatty liver disease: a clinical review. Dig Dis Sci, 50, 171-80. DOI |
24 | Scheuer PJ, Ashrafzadeh P, Sherlock S, Brown D, Dusheiko G M (1992). The pathology of hepatitis C. Hepatology, 15, 567-71. DOI |
25 | Schiff ER, Sorell MF, WC M (1999). Disease of the Liver., Philedelphia: Lippincot- Williams and Wilkins. |
26 | Shi JP, Fan JG, Wu R, et al (2008). Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection. J Gastroenterol Hepatol, 23, 1419-25. DOI |
27 | Starley BQ, Calcagno CJ, Harrison SA (2010). Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology, 51, 1820-32. DOI ScienceOn |
28 | Minakari M, Molaei M, Shalmani HM, et al (2009). Liver steatosis in patients with chronic hepatitis B infection: host and viral risk factors. Eur J Gastroenterol Hepatol, 21, 512-6. DOI ScienceOn |
29 | Thomopoulos KC, Arvaniti V, Tsamantas AC, et al (2006). Prevalence of liver steatosis in patients with chronic hepatitis B: a study of associated factors and of relationship with fibrosis. Eur J Gastroenterol Hepatol, 18, 233-7. DOI |
30 | Matteoni CA, Younossi ZM, Gramlich T, et al (1999). Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology, 116, 1413-9. DOI ScienceOn |
31 | Nascimento AC, Maia DR, Neto SM, et al (2012). Nonalcoholic Fatty liver disease in chronic hepatitis B and C patients from Western Amazon. Int J Hepatol, 2012, 695950. |
32 | Petta S, Camma C, Di Marco V, et al (2011). Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection. Liver Int, 31, 507-15. DOI |
33 | Walsh MJ, Vanags DM, Clouston AD, et al (2004). Steatosis and liver cell apoptosis in chronic hepatitis C: a mechanism for increased liver injury. Hepatology, 39, 1230-8. DOI ScienceOn |
34 | Wan G, Ohnomi S, Kato N (2000). Increased hepatic activity of inducible nitric oxide synthase in rats fed on a high-fat diet. Biosci Biotechnol Biochem, 64, 555-61. DOI ScienceOn |
35 | Bach N, Thung SN, Schaffner F (1992). The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology, 15, 572-7. DOI |
36 | Basaranoglu M, Basaranoglu G (2011). Pathophysiology of insulin resistance and steatosis in patients with chronic viral hepatitis. World J Gastroenterol, 17, 4055-62. DOI |
37 | Yang S, Lin H, Diehl AM (2001). Fatty liver vulnerability to endotoxin-induced damage despite NF-kappaB induction and inhibited caspase 3 activation. Am J Physiol Gastrointest Liver Physiol, 281, 382-92. DOI |
38 | Yang SQ, Lin HZ, Lane MD, Clemens M, Diehl AM (1997). Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci USA, 94, 2557-62. DOI ScienceOn |
39 | Na TY, Shin YK, Roh KJ, et al (2009). Liver X receptor mediates hepatitis B virus X protein-induced lipogenesis in hepatitis B virus-associated hepatocellular carcinoma. Hepatology, 49, 1122-31. DOI ScienceOn |
40 | Yoon EJ, Hu KQ (2006). Hepatitis C virus (HCV) infection and hepatic steatosis. Int J Med Sci, 3, 53-6. |
41 | Peng D, Han Y, Ding H, Wei L (2008). Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors. J Gastroenterol Hepatol, 23, 1082-8. DOI ScienceOn |
42 | Ates F, Yalniz M, Alan S (2011). Impact of liver steatosis on response to pegylated interferon therapy in patients with chronic hepatitis B. World J Gastroenterol, 17, 4517-22. DOI |
43 | Gordon A, Mclean CA, Pedersen JS, Bailey MJ, Roberts SK (2005). Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis. J Hepatol, 43, 38-44. DOI |
![]() |